Liver biopsies for chronic hepatitis C: Should nonultrasound-guided biopsies be abandoned?

Canadian Journal of Gastroenterology

Volumn 23, Issue 6, 2009, Pages 425-430

  Flemming, Jennifer A ^a   Hurlbut, David J ^a   Mussari, Ben ^a   Hookey, Lawrence C ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b HOTEL DIEU HOSPITAL   (Canada)

Author keywords

Biopsy; HCV; Liver

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; AGE; ANALYTICAL PARAMETERS; ARTICLE; BILIRUBIN BLOOD LEVEL; COMPLETE PORTAL TRACT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; FRAGMENTATION REACTION; GOLD STANDARD; HEMATOMA; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; SEX DIFFERENCE; TISSUE SECTION;

EID: 69949098401     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/370651     Document Type: Article

References (29)

1. Bravo AA, Sunil GS, Chopra S. Current concepts: Liver biopsy. N Eng J Med 2001;344:495-500.
2. Guido C, Guido M, Sonzogni A, Leandro G, Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003;39:239-44.
3. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: A quantitative reference standard. Hepatology 1998;28:323-31.
4. Guido M, and Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2003;24:84-96.
5. Cholongitas E, Senzolo M, Standish R, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol 2006;125:710-21.
6. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: Results of a prospective nationwide survey. Hepatology 2000;32:477-81.
7. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies. Liver Int 2008;28:705-12.
8. Gilmore IT, Burroughs A, Murray-Lyon IM, et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: Audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995;36:437-41.
9. Lindor KD, Bru C, Jorgensen RA, et al. The role of ultrasonography and automatic needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079-83.
10. Farrell RJ, Smiddy PF, Pilkington RM, et al. Guided versas blind liver biopsy for chronic hepatitis C: Clinical benefits and costs. J Hepatol 1999;30:580-7.
11. Pasha T, Gabriel S, Therneau T, et al. Cost effectiveness of ultrasound-guided liver biopsy. Hepatology 1998;27:1220-6.
12. Younossi ZM, Teran JC, Ganiats TG, Carey WD. Ultrasound-guided liver biopsy for parenchymal liver disease. An economic analysis. Dig Dis Sci 1998;43:46-50.
13. Jacobs WH, Goldberg SB. Patient Care Committee of the American Gastroenterological Association. Statement on outpatient percutaneous liver biopsy. Dig Dis Sci 1989;34:322-3.
14. Abdalian R, Siadat F, Heathcote EJ, Guindi M. Adequacy of liver biopsies: Variability across different methods of specimen acquisition. Can J Gastroenterol 2008;22(Suppl A): 168 (Abst).
15. Angtuaco TL, Lal SK, Banaad-Omiotek GD, et al. Current liver biopsy practices for suspected parenchymal liver diseases in the United States: The evolving role of radiologists. Am J Gastroenterol 2002;97: 1468-71.
16. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17.
17. Yano M, Kumada H, Kage M, et al. The long-term pathological evaluation of chronic hepatitis C. Hepatology 1996;23:1334-40.
18. Poynard T, Bedossa P, Opolon P. The natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
19. Grant A, Neuberger J. Guidelines for the use of liver biopsy in clinical practice. Gut 1999;45 (Suppl. 1): 1-11.
20. Chevallier P, Ruitort F, Denys A, et al. Influence of operator experience on the performance of ultrasound-guided percutaneous liver biopsy. Eur Radiol 2004; 14:2086-91.
21. Gilmore IT, Burroughs A, Murray-Lyon IM, et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: An audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1999;45 (Suppl IV): 1-11.
22. Froehlich F, Lamy O, Fried M, et al. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci 1993;38:1480-4.
23. Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,267 biopsies. J Hepatol 1986;2:165-173.
24. Wawrzynowicz-Syczewska M, Kruszewski T, Boron-Kaczmarska A. Complications of percutaneous liver biopsy. Rom J Gastroenterol 2002;2:105-7.
25. McGill DB, Rakela J, Zinsmeister AR, and Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;5:1396-1400.
26. van der Poorten D, Kwok A, Lam T, et al. Twenty-year audit for percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J 2006;36:692-9.
27. Garcia-Tsao, G, Boyer J. Outpatient liver biopsy: How safe is it?, Ann Inter Med 1993; 118:150-3.
28. Gibbs DH, Opelka FG, Beck DE, et al. Postpolypectomy colonic hemorrhage. Dis Colon Rectum 1996;39:806-10.
29. Ontario Health Insurance Plan Schedule of Benefits and Fees. Digestive System Surgical Procedures. April, 2008.